B. MİCHELSEN Et Al. , "Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network.," 2019 ACR/ARHP Annual Meeting , vol.71, ATLANTA, United States Of America, pp.1-5420, 2019
MİCHELSEN, B. Et Al. 2019. Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network.. 2019 ACR/ARHP Annual Meeting , (ATLANTA, United States Of America), 1-5420.
MİCHELSEN, B., ORNBJERG, L., LOFT, A., KVİEN, T., CİUREA, A., MANN, H., ... EKLUND, K.(2019). Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network. . 2019 ACR/ARHP Annual Meeting (pp.1-5420). ATLANTA, United States Of America
MİCHELSEN, BRİGİTTE Et Al. "Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network.," 2019 ACR/ARHP Annual Meeting, ATLANTA, United States Of America, 2019
MİCHELSEN, BRİGİTTE Et Al. "Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network.." 2019 ACR/ARHP Annual Meeting , ATLANTA, United States Of America, pp.1-5420, 2019
MİCHELSEN, B. Et Al. (2019) . "Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network.." 2019 ACR/ARHP Annual Meeting , ATLANTA, United States Of America, pp.1-5420.
@conferencepaper{conferencepaper, author={BRİGİTTE MİCHELSEN Et Al. }, title={Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network.}, congress name={2019 ACR/ARHP Annual Meeting}, city={ATLANTA}, country={United States Of America}, year={2019}, pages={1-5420} }